DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Psoriasis Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The report provides insights into Psoriasis epidemiology, Psoriasis diagnosed patients, and Psoriasis treatment rate for EU5 pharmaceutical markets.
The study measures key indicators such as prevalence of Psoriasis derived from epidemiological analysis, percentage of patients diagnosed with Psoriasis, and percentage of patients treated with a therapy.
The study helps executives estimate Psoriasis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Psoriasis prevalence, Psoriasis diagnosis rate, and Psoriasis treatment rate for the period 2016 - 2025.
Key Features of the Report:
- Psoriasis Patient Flow
- Psoriasis Prevalence
- Psoriasis Diagnosed Patients
- Psoriasis Treated Patients
Key Topics Covered:
1. Psoriasis: Disease Definition
2. Psoriasis Patient Flow in Europe
3. Psoriasis Patient Flow in Germany
4. Psoriasis Patient Flow in France
5. Psoriasis Patient Flow in Spain
6. Psoriasis Patient Flow in Italy
7. Psoriasis Patient Flow in UK
For more information about this report visit http://www.researchandmarkets.com/research/p2h23v/europe_psoriasis